Vintró-Alcaraz, Cristina
Mestre-Bach, Gemma
Granero, Roser
Cuquerella, Àngel
Talón-Navarro, María-Teresa
Valenciano-Mendoza, Eduardo
Mora-Maltas, Bernat
del Pino-Gutiérrez, Amparo
Gómez-Peña, Mónica
Moragas, Laura
Fernández-Aranda, Fernando
Codina, Ester
Valero-Solís, Susana
Guillén-Guzmán, Elías
Lara-Huallipe, Milagros Lizbeth
Solé-Morata, Neus
Jiménez-Murcia, Susana http://orcid.org/0000-0002-3596-8033
Funding for this research was provided by:
Ministerio de Ciencia, Innovación y Universidades (RTI2018-101837-B-100)
Ministerio de Sanidad, Servicios Sociales e Igualdad (FIS PI14/00290, FIS PI17/01167)
Delegación del Gobierno para el Plan Nacional sobre Drogas (2017I067, 2019I47)
Article History
Accepted: 1 October 2021
First Online: 15 October 2021
Declarations
:
: FFA received consultancy honoraria from Novo Nordisk and editorial honoraria as EIC from Wiley. The rest of the authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.
: This study was done in compliance with the Helsinki Declaration of 1975 as revised in 1983, and the Committee of the institution involved in the project approved the study.
: Signed informed consent was obtained from all participants.
: Consent for publication of this article has been obtained from all authors.